Class information for:
Level 1: BIOMED SURG CELL BIOL//MED CHILDRENS CLIN//RHIGF I THERAPY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17283 543 36.9 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
120 23422 GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//INSULIN LIKE GROWTH FACTOR I

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOMED SURG CELL BIOL Address 2 67% 0% 2
2 MED CHILDRENS CLIN Address 1 38% 1% 3
3 RHIGF I THERAPY Author keyword 1 50% 0% 2
4 RHIGF I Author keyword 1 33% 1% 3
5 INSULIN REQUIREMENTS Author keyword 1 25% 1% 3
6 SHEIKH RASHID Address 1 33% 0% 2
7 ANTERIOR CHAMBER ANOMALIES Author keyword 1 50% 0% 1
8 AUTOIMMUNITY PREVENTION Author keyword 1 50% 0% 1
9 BB W RATS Author keyword 1 50% 0% 1
10 DIABETES MELLITUS TYPE 1 COMPLICATIONS Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 RHIGF I THERAPY 1 50% 0% 2 Search RHIGF+I+THERAPY Search RHIGF+I+THERAPY
2 RHIGF I 1 33% 1% 3 Search RHIGF+I Search RHIGF+I
3 INSULIN REQUIREMENTS 1 25% 1% 3 Search INSULIN+REQUIREMENTS Search INSULIN+REQUIREMENTS
4 ANTERIOR CHAMBER ANOMALIES 1 50% 0% 1 Search ANTERIOR+CHAMBER+ANOMALIES Search ANTERIOR+CHAMBER+ANOMALIES
5 AUTOIMMUNITY PREVENTION 1 50% 0% 1 Search AUTOIMMUNITY+PREVENTION Search AUTOIMMUNITY+PREVENTION
6 BB W RATS 1 50% 0% 1 Search BB+W+RATS Search BB+W+RATS
7 DIABETES MELLITUS TYPE 1 COMPLICATIONS 1 50% 0% 1 Search DIABETES+MELLITUS++TYPE+1+COMPLICATIONS Search DIABETES+MELLITUS++TYPE+1+COMPLICATIONS
8 DIABETES MELLITUS TYPE 2 COMPLICATIONS 1 50% 0% 1 Search DIABETES+MELLITUS++TYPE+2+COMPLICATIONS Search DIABETES+MELLITUS++TYPE+2+COMPLICATIONS
9 DQ HAPLOTYPES 1 50% 0% 1 Search DQ+HAPLOTYPES Search DQ+HAPLOTYPES
10 DURATION OF DIABETES MELLITUS 1 50% 0% 1 Search DURATION+OF+DIABETES+MELLITUS Search DURATION+OF+DIABETES+MELLITUS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FACTOR I THERAPY 6 80% 1% 4
2 DAWN PHENOMENON 6 20% 5% 25
3 DUAL HORMONAL REPLACEMENT 6 100% 1% 4
4 NEOVASCULAR EYE DISEASE 6 100% 1% 4
5 ANGIOGENIC AGENT 5 63% 1% 5
6 RHIGF I 3 35% 1% 8
7 BOVINE NEURAL RETINA 1 100% 0% 2
8 EXTREME INSULIN RESISTANCE 1 50% 0% 2
9 MECASERMIN RINFABATE 1 40% 0% 2
10 PITUITARY ABLATION 1 40% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Involvement of insulin-like growth factor-I in the control of glucose homeostasis 2006 49 43 42%
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX (TM) 2008 14 80 43%
Insulin like growth factor-I and diabetes. A review 1998 40 67 48%
IGF-I and diabetes in adolescence 1998 23 65 65%
Growth Abnormalities in Children with Type 1 Diabetes, Juvenile Chronic Arthritis, and Asthma 2014 1 86 41%
The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis 2003 96 116 28%
An ocular view of the IGF-IGFBP system 2013 3 108 19%
Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1 2007 94 63 13%
Insulin-like growth factor I: Physiology, metabolic effects and clinical uses 1996 58 88 27%
Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy 2000 48 70 30%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOMED SURG CELL BIOL 2 67% 0.4% 2
2 MED CHILDRENS CLIN 1 38% 0.6% 3
3 SHEIKH RASHID 1 33% 0.4% 2
4 MRL WELLCOME TRUST MRC METAB SCI 1 50% 0.2% 1
5 ST THOMAS HOSP ENDOCRINOL CHEM PATHOL 1 50% 0.2% 1
6 NUTR ENDOCRINOL METAB 1 22% 0.4% 2
7 ABT PADIATR ENDOKRINOL DIABETOL 0 33% 0.2% 1
8 CHILDRENS NATIONWIDE KIDNEY 0 33% 0.2% 1
9 DEAN A MCGEE 0 33% 0.2% 1
10 DIABET AMBULANZ MNR KLIN 0 33% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000207094 URINARY IGF I//RENAL HYPERTROPHY//SUB MOL ENDOCRINOL
2 0.0000168027 IGFBP 5//INSULIN LIKE GROWTH FACTOR BINDING PROTEIN//IGFBP 3
3 0.0000166661 SALFORD ROYAL HOSP UNIV TRUST//MED 0613B//MED HUMAN LIFE SCI
4 0.0000160307 MECHANO GROWTH FACTOR//MECHANO GROWTH FACTOR MGF//IGF 1 ISOFORMS
5 0.0000129969 CC MORFOL FISIOL//SCI POLYMER TECHNOL//MAC25
6 0.0000112641 CARBOHYDRATE COUNTING//FLEXIBLE INTENSIVE INSULIN THERAPY//POPULATION BASED TRIAL
7 0.0000105033 HYPERCYTOLIPIDEMIA//DIABETES DB DB MUTATION//DIABETES OBESITY SYNDROME
8 0.0000094758 LARON SYNDROME//GROWTH HORMONE RECEPTOR//GROWTH HORMONE INSENSITIVITY
9 0.0000088239 DIPARTIMENTO SCI MED DIAGNOST//HEPATOL 5//PL MOL MED IMMA BOADILLA DEL MONTE
10 0.0000079433 C PEPTICLE//CLIN PHYSIOL METAB UNIT//HENRY WELLCOME S EGRATED CELL SIGNALLING